Trump announces price cuts on Wegovy, Zepbound

President Donald Trump has unveiled a deal with drugmakers Eli Lilly and Novo Nordisk to reduce prices for their obesity ...
Drug Store News

President Trump announces deals with Eli Lilly, Novo Nordisk to slash prices on GLP-1s

The prices of Ozempic and Wegovy will fall from $1,000 and $1,350 per month, respectively, to $350 when purchased through ...

Eli Lilly Crushed Novo In Obesity Drug Battle—Trump Now Forces Price Cuts

Trump secures a major deal with Eli Lilly and Novo Nordisk to cut obesity drug costs as Medicare expands coverage for ...
Clinical Advisor

Trump Announces Major Price Cut for Ozempic, Wegovy and Similar Drugs

The deal involves Eli Lilly, which makes Zepbound and Mounjaro, and Novo Nordisk, the maker of Ozempic and Wegovy. The drugs, known as GLP-1 medications, now cost as much as $1350 a month. Under the ...
Fierce Pharma

Novo forges partnership with Emcure to expand Wegovy access in India

Just five months after Novo Nordisk launched Wegovy in India, the Danish company has partnered (PDF) with Emcure ...

Novo Nordisk trims outlook as obesity drug maker loses ground to Eli Lilly

COPENHAGEN (Reuters) -Wegovy-maker Novo Nordisk trimmed its full-year forecasts on Wednesday as sales growth of its ...
NJBIZ

Novo Nordisk, Eli Lilly cut GLP-1 drug costs under Medicare

Novo Nordisk and Eli Lilly reached deals to lower GLP-1 drug costs for Medicare and Medicaid patients under Trump’s new ...

Eli Lilly's Breakout Is Here - Growing GLP-1 Market Share

Eli Lilly's Mounjaro and Zepbound deliver accelerated weight loss rates compared to Novo Nordisk's Wegovy. Learn why LLY ...